BioCentury
ARTICLE | Company News

PharmaCell B.V., TiGenix deal

June 9, 2014 7:00 AM UTC

PharmaCell completed the purchase of TiGenix's cGMP cell therapy production facility for €5.8 million ($7.8 million) (see BioCentury, Feb. 3). ...